Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.970
+0.120 (4.21%)
Aug 13, 2025, 4:00 PM - Market closed
JSPR's stock price has decreased by -82.29% in the past year and price targets may not have had time to catch up.
Jasper Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$31.67
Upside
+966.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy → Hold Downgrades $15 → $4 | Buy → Hold | Downgrades | $15 → $4 | +34.68% | Jul 8, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $70 → $12 | Buy | Maintains | $70 → $12 | +304.04% | Jul 8, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $50 → $20 | Buy | Maintains | $50 → $20 | +573.40% | Jul 8, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +573.40% | Jul 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2025 |
| BTIG | BTIG | Strong Buy Maintains $64 → $20 | Strong Buy | Maintains | $64 → $20 | +573.40% | Jul 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $80 → $65 | Buy | Maintains | $80 → $65 | +2,088.55% | May 15, 2025 |
| UBS | UBS | Strong Buy Maintains $38 → $33 | Strong Buy | Maintains | $38 → $33 | +1,011.11% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +1,246.80% | Mar 11, 2025 |
| UBS | UBS | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +1,179.46% | Feb 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $70 | Buy | Reiterates | $70 | +2,256.90% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +1,246.80% | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $68 → $48 | Buy | Maintains | $68 → $48 | +1,516.16% | Jan 9, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $70 | Buy | Maintains | $70 | +2,256.90% | Jan 6, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $68 | Buy | Reiterates | $68 | +2,189.56% | Dec 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.